Latest Conference Articles

While many areas of multiple sclerosis treatment have made progress in recent years working to help patients through issues with cognition is still an inexact science though work is being done to correct that.

The US Army Medical Research Institute of Infectious Diseases reports promising preclinical results on an antiviral for Ebola. In findings presented at ID Week 2015 in San Diego, CA, Travis Warren, PhD, a principal investigator said a collaboration with Gilead on a compound known as GS-5734 completely protected rhesus monkeys after they were infected with the virus.

In the UK's National Health Service, physicians are "bare below the elbows" meaning they wear scrubs and not white coats, dress shirts and ties. At ID Week, in an entertaining but serious debate, two infection control specialists tackled the question of whether US physicians should also go bare.

ID Week is the most relevant and important meeting for ID as a whole.

The Lahey Hospital & Medical Center's use of less intensive immunosuppressants contributes to the fewer incidences of infectious disease complications in transplant patients.

Nine million US children have not been vaccinated for measles, raising concerns that there could be major outbreaks of the illness, researchers said at ID Week 2015.

Neurologists seeing patients with seizures who are from developing countries in Latin America, sub-Saharan Africa and other countries with much poverty and poor sanitation should be on the lookout for neurocysticercosis, a condition related to exposure to tapeworms.

As a medical epidemiologist for Long-term Care in the Division of Healthcare Quality Promotion at the Centers for Disease Control and Prevention (CDC), Nimalie Stone ensures seven core elements of stewardship are maintained throughout longterm care: leadership commitment, accountability, drug expertise, action, tracking, reporting, and education.

Nursing homes of today are what hospitals looked like 10 or 15 years ago.

Enterovirus D68 caused hundreds of hospitalizations and five deaths across the US in 2014. It left many mysteries, including why so many people got it since a CDC study showed the US populace is basically immune the virus, one discovered in 1962. Why it was linked to paralysis in some children is also unclear. But three experts at ID Week 2015 today agreed, EV-D68 will be back.

Patients on non-recommended treatment regimens are less likely to achieve viral suppression and more likely to report side effects.

Researchers report that waiting more than 2 years between HIV screenings is associated with double the rate of AIDS by CD4+ criteria at the time of HIV diagnosis when compared with more frequent testing.

The new guidelines provide important updates in four key areas, including behavioral screening for possible HIV transmission, sexually transmitted disease screening and treatment, HIV partner services, and referral for medical and social services.

The ECTRIMS conference may be based in Europe but as the conference has grown so has its global impact on multiple sclerosis treatment. With topics ranging from newly approved therapies to those in the pipeline to those not yet ready for testing there is lots to learn in the yearly event.

In the world of multiple sclerosis treatment the relapsing remitting form of the disease is well ahead of the primary progressive form.

A pair of phase III studies revealed positive efficacy and safety outcomes for ocrelizumab, and this could be a game-changer for patients with multiple sclerosis (MS).

Overuse of urinary catheters is a common problem in all hospitals. Intervention is possible.

A University of Colorado School of Medicine hypothesized that the nasal microbiome could be protective against MRSA colonization in some individuals. Reporting at ID Week 2015 in San Diego, CA, Mary Bessenden, MD and colleges looked at 26 persistently MRSA colonized people and 26 non-colonized controls.

Patients with multiple sclerosis (MS) commonly experience tremoring limbs, head pain, and blurred vision, among other symptoms. Fatigue is another commonly reported and has the power to alter a patient's quality of life (QoL). But by how much?

Results from clinical trials that included patients with relapsing-remitting multiple sclerosis (RRMS) do not appear to be consistent for patients with primary progressive multiple sclerosis (PPMS), according to Markus W. Koch, MD, from the University of Calgary in Alberta, Canada.

It's not uncommon for patients with multiple sclerosis (MS) to experience a reduction in brain volume. However, treatment with alemtuzumab can slow the process, according to a multi-continental team of investigators.

The problem of antibiotic resistance is a national health problem, a national security problem, and a global problem. The hope is that we'll get more of our citizens involved and active in playing a role in addressing this crisis.

For patients with multiple sclerosis (MS), disturbances in the thermoregulation can result in episodic hypothermia. It's believed that this is caused by hypothalamic lesions from the disease, however, the specifics are not fully understood. M. Toledano and colleagues from the University of Utah set out to uncover more in a poster session that will be presented at the 31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2015) in Barcelona, Spain.

Katarina Fink, an associate in the Department of Clinical Neuroscience at the Karolinska Institutet in Sweden, and colleagues analyzed the influence that multiple sclerosis (MS) has on a woman's fertility – an area that has remained unclear. The findings will be described in a poster session at the 31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2015) in Barcelona, Spain.

Hospital-associated infections can be better identified and contained through technology, a multi-institutional team reports.

MR-PET imaging can reveal inflammation and neurodegeneration in the brain, among other things, and a recent study showed that it can also help determine the progression of multiple sclerosis (MS).

With some patients being treated for multiple sclerosis with Aubagio for more than a decade questions have been raised about the safety of the treatment for such a long period of time. Further research has shown it to still be safe for the people who need it most.

It can be easy to look at the treatment of multiple sclerosis and stop at the physical symptoms of the disease. For patients living with the condition their daily lives are about more than the symptoms and making them work within their own individual challenges.

Young suburban heroin users who were admitted recently to a Princeton, NJ drug rehab facility showed an unexpectedly high incidence of hepatitis C infection.

Magnetic resonance imaging (MRI) can be used to identify lesions in the central nervous system in patients with multiple sclerosis (MS), but not all patients with active disease have identifiable lesions, and researchers are mixed over the extent to which lesions can be used as a marker for MS disease activity.